Cell-based Assays Market

Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecast to 2025

Report Code: BT 2486 Mar, 2021, by marketsandmarkets.com

[239 Pages Report] The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period. The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.

Cell-based Assays Market

To know about the assumptions considered for the study, download the pdf brochure

Covid-19 Impact On The Global Cell-Based Assays Market

The COVID-19 pandemic has increased the burden on healthcare systems across the globe. According to the WHO, there were 96,012,792 confirmed cases of COVID-19, including 2,075,870 deaths (as of January 22, 2021). Due to the pandemic, companies have scaled up R&D efforts to develop a vaccine and drugs against the SARS-CoV-2 virus. Vaccine-related research activities in pharmaceutical & biotechnological companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Due to the increase in research activities, both the availability of funding for research and the demand for and manufacturing of cell-based assay products are expected to grow.

The players operating in the market are altering their long-term and short-term growth strategies by tapping into opportunities prevalent in the research market by developing innovative products to combat the pandemic. The increased demand for research on COVID-19 has created a large scope for cell-based 45 assays in viral infection research, vaccine development, and overall drug discovery for both researchers and laboratories.

Currently, a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development, and patients are currently treated symptomatically. For both vaccines and therapeutics, the antibodies produced are tested for their functional efficacy to neutralize the target virus. Cell-based assays are employed to shorten the time and increase the throughput needed for these assays. This has significantly increased the demand for cell-based assays to provide an early indication of the toxicity characteristics of the drug candidates.

Cell-based Assays market dynamics

Driver: Growing preference for cell-based assays in drug discovery

Cell-based assays are key components in the drug development process. Cell-based assays have several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays. It is also not possible to prepare or purify every target for biochemical measurement, which is a major factor limiting the applications of biochemical assays. As a result, pharmaceutical & biotechnology companies as well as CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery.

The conventional methods of toxicity and drug safety assessment (involving animal testing) are expensive, time-consuming, and offer low-throughput. In this regard, modern cell-based assays merge the advantages of cell cultures and animal models to allow researchers to identify problems with lead compounds in early screening, ensuring greater efficiency in the drug discovery and development process. Additionally, the physiological relevance of cell-based assays, as well as their ability to provide efficient, cost-effective, and accelerated drug discovery solutions, has also fueled their greater adoption among end users.

Resatraint: High cost of instruments and restrictions on reagent use

The introduction of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell-based assays has increased their reliability. However, these technologies have also resulted in a significant increase in the cost of instruments. Moreover, the time and cost involved in each HTS process are directly proportional to the target molecule’s complexity; consequently, the higher the complexity, the greater the cost. In biopharmaceutical companies, the overall cost of production of biopharmaceuticals has increased considerably due to the use of these expensive systems. Academic research laboratories find it difficult to afford such expensive instruments due to budgetary restrictions. Maintenance costs and other indirect expenses result in an overall increase in the total cost of ownership of these instruments.

The growth of the reagents market is restricted by a different factor—product end-user licenses restrict the use of reagent kits only to specified assays. Due to this, even though better and superior reagents are available in the market, customers are restricted to using only those reagents specified in the license agreement. This may act as a barrier to the growth of the cell-based assays market.

Opportunity: Emerging markets

Emerging countries in Asia are expected to offer significant growth opportunities for players operating in the cell-based assays market owing to the low labor and raw material costs, increased risk of pandemics (such as swine flu and COVID-19), growth in the number of research activities, and technological advancements in the end-use sectors for cell-based assays in these countries.

A number of Asian governments have increased their focus on life science research over the last few years. For instance, the Global Health Innovative Technology (GHIT) Fund is a public-private partnership in Japan that funds various R&D activities for drug discovery, which also includes the screening of compound libraries related to various infectious diseases. R&D spending for new drug development is a critical growth driver for the global cell-based assays market. According to estimates from the World Bank, the R&D spending in emerging economies in Asia and RoW has surpassed that of North America and Europe. Additionally, the increasing number of pharmaceutical companies and CROs—key end-users of cell-based assays—in these countries is expected to offer potential growth opportunities for manufacturers of cell-based assays.

By product and service, the consumables segment accounted for the largest share of the cell-based assays market in 2019.

Based on product and service, the cell-based assays market is segmented into consumables, instruments & software, and services. Consumables dominated the market in 2019. The large share of this segment can be attributed to the extensive use and repeated purchase of consumables by pharmaceutical and biopharmaceutical companies and the rising number of preliminary studies for the development of therapeutics.

By application, the drug discovery segment accounted for the largest share of the cell-based assays market in 2019.

Based on application, the cell-based assays market is categorized into drug discovery, basic research, and other applications. The drug discovery application segment dominated the market in 2019. The large share of the drug discovery segment can be attributed to increasing R&D investments, technological innovations in supportive processes, the introduction of new drugs, and the growing number of CROs providing drug discovery services.

By end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the cell-based assays market in 2019.

Based on end users, the cell-based assays market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes. Pharmaceutical & biotechnology companies dominated the market in 2019. The large share of this segment can be attributed to the increase in R&D expenditure, the growing number of drug discovery projects, and the adoption of strategic approaches such as collaborations to develop drug candidates.

North America accounted for the largest share of the cell-based assays market in 2019.

In 2019, North America accounted for the largest share of the cell-based assays market, followed by Europe. The large share of the North American regional segment can be attributed to the availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, and the rapid adoption of advanced technologies in the region.

Cell-based Assays Market  by Region

Key Market Players

Becton, Dickinson and Company (US) are the prominent players operating in the cell-based assays market.

Scope of the report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD Billion)

Segments Covered

Product and Service, Application, End User and Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Companies Covered

The major market players include  as Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US) among others.
(Total 25 companies)

The study categorizes the cell-based assays market into the following segments and subsegments:

Product And Service

  • Consumables
    • Reagents
    • Assay Kits
      • Reporter Gene Assays
      • Cell Growth Assays
      • Second Messenger Assays
      • Cell Death Assays
      • Other Assay Kits
  • Cell Lines
    • Immortalized Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
  • Microplates
  • Probes & Labels
  • Other Consumables
  • Instruments & Software
  • Services

Type

  • Drug Discovery
    • Toxicity Studies
    • Pharmacodynamic Studies
    • Pharmacokinetic Studies
  • Basic Research
  • Other Applications

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • CROs
  • Academic & Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • The Middle East and Africa

Recent Developments

  • In 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System.
  • In 2020, Thermo Fisher Scientific (US) acquired Phitonex, Inc. (US). The acquisition of spectral dye platform manufacturer Phitonex will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities in protein and cell analysis research.
  • In 2020, Charles River Laboratories entered into a multi-year drug discovery collaboration with Karuna Therapeutics, a US-based CRO, to expand its drug discovery capabilities.
  • In 2020, Danaher Corporation completed the acquisition of GE Healthcare’s biopharma business and renamed as Cytiva.
  • In 2018, Lonza Group AG (Switzerland) established its Collaborative Innovation Center in the new Life Science Park on the outskirts of Haifa, Israel. This center focuses on the R&D projects of Lonza’s Pharma Biotech & Nutrition segment.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
           FIGURE 1 PRIMARY SOURCES
           FIGURE 2 CELL-BASED ASSAYS MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION
           FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2019
           FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2019
           FIGURE 5 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS, 2020–2025
           FIGURE 6 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 44)
           FIGURE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 CELL-BASED ASSAYS MARKET, BY END USER (USD MILLION)
           FIGURE 11 GEOGRAPHICAL SNAPSHOT: CELL-BASED ASSAYS MARKET

4 PREMIUM INSIGHTS (Page No. - 47)
    4.1 CELL-BASED ASSAYS MARKET OVERVIEW
           FIGURE 12 RISING DRUG DISCOVERY ACTIVITY IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
    4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2019)
           FIGURE 13 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2019
    4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION (2019)
           FIGURE 14 DRUG DISCOVERY COMMANDED THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN 2019
    4.4 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 15 CHINA IS THE FASTEST-GROWING MARKET FOR CELL-BASED ASSAYS

5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 16 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Growing preference for cell-based assays in drug discovery
                    5.2.1.2 Increasing funding for cell-based research
                    5.2.1.3 Growth in the number of drug discovery activities
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of instruments and restrictions on reagent use
                    5.2.2.2 Lack of infrastructure for cell-based research in emerging economies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies
                    5.2.3.2 Growing risk of pandemics and communicable diseases
                    5.2.3.3 Application of novel cell-based assays in cancer research
    5.3 IMPACT OF COVID-19 ON THE CELL-BASED ASSAYS MARKET
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 17 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS
           FIGURE 18 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS
           FIGURE 19 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS

6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE (Page No. - 57)
    6.1 INTRODUCTION
           TABLE 1 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
    6.2 CONSUMABLES
           TABLE 2 CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 3 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 4 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 5 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 6 CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           6.2.1 REAGENTS
                    6.2.1.1 Expanded applications of reagents propel market growth for the segment
           TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 8 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 9 EUROPE: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 10 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.2 ASSAY KITS
           TABLE 11 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 12 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 13 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 14 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 15 ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    6.2.2.1 Reporter gene assays
                               6.2.2.1.1 Reporter gene assays can be used with limited resources to establish HTS platforms, representing opportunities for small laboratories with limited resources
           TABLE 16 REPORTER GENE ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 17 NORTH AMERICA: REPORTER GENE ASSAYS REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 18 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 19 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.2.2 Cell growth assays
                               6.2.2.2.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
           TABLE 20 CELL GROWTH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 21 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 22 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 23 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.2.3 Second messenger assays
                               6.2.2.3.1 These assays are used to detect and characterize all compound classes
           TABLE 24 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 25 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 26 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 27 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.2.4 Cell death assays
                               6.2.2.4.1 Cell death quantification is essential to identify how potential drugs could inhibit or enhance molecular targets
           TABLE 28 CELL DEATH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 29 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 30 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 31 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.2.5 Other assay kits
           TABLE 32 OTHER ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 33 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 34 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 35 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.3 MICROPLATES
                    6.2.3.1 Extensive use of microplates for assay development is encouraging the consumption of these products
           TABLE 36 MICROPLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 37 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 38 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 39 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.4 CELL LINES
           TABLE 40 CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 41 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 42 EUROPE: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 43 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 44 CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    6.2.4.1 Immortalized cell lines
                               6.2.4.1.1 Immortalized cell lines are widely used owing to their ease of use, cost-effectiveness, and high availability of material
           TABLE 45 IMMORTALIZED CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 46 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 47 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 48 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.4.2 Primary cell lines
                               6.2.4.2.1 Primary cell lines find demand in a range of applications
           TABLE 49 PRIMARY CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 50 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 51 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 52 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    6.2.4.3 Stem cell lines
                               6.2.4.3.1 Stem cell lines find applications in therapy development and regenerative medicine
           TABLE 53 STEM CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 54 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 55 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 56 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.5 PROBES & LABELS
                    6.2.5.1 Effective labeling of cells helps in studying cellular events
           TABLE 57 PROBES & LABELS MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 58 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 59 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 60 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.6 OTHER CONSUMABLES
           TABLE 61 OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 62 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 63 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 64 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 INSTRUMENTS & SOFTWARE
           6.3.1 TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION IN INSTRUMENTS AND RISING USE OF SOFTWARE DRIVE THE GROWTH OF THE SEGMENT
           TABLE 65 INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 66 NORTH AMERICA: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 67 EUROPE: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 68 ASIA PACIFIC: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.4 SERVICES
           6.4.1 RISING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE SEGMENT GROWTH
           TABLE 69 SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 70 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 71 EUROPE: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 72 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

7 CELL-BASED ASSAYS MARKET, BY APPLICATION (Page No. - 93)
    7.1 INTRODUCTION
           TABLE 73 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    7.2 DRUG DISCOVERY
           TABLE 74 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 75 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 76 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 77 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 78 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           7.2.1 TOXICITY STUDIES
                    7.2.1.1 Increasing adoption of high-content screening for cytotoxicity testing to fuel growth in this segment
           TABLE 79 TOXICITY STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 80 NORTH AMERICA: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 81 EUROPE: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 82 ASIA PACIFIC: TOXICITY STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.2 PHARMACOKINETIC STUDIES
                    7.2.2.1 Rising importance of ADME studies in pharmacokinetics to propel the demand for advanced cell-based assay technologies
           TABLE 83 PHARMACOKINETIC STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 84 NORTH AMERICA: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 85 EUROPE: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 86 ASIA PACIFIC: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.3 PHARMACODYNAMIC STUDIES
                    7.2.3.1 Expanded use of cell-based assays to study pharmacodynamics to propel the growth of the segment
           TABLE 87 PHARMACODYNAMIC STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 88 NORTH AMERICA: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 89 EUROPE: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 90 ASIA PACIFIC: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 BASIC RESEARCH
           7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
           TABLE 91 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 92 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 93 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 94 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.4 OTHER APPLICATIONS
           TABLE 95 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 96 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 97 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 98 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)

8 CELL-BASED ASSAYS MARKET, BY END USER (Page No. - 109)
    8.1 INTRODUCTION
           TABLE 99 CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
           8.2.1 GROWING R&D ACTIVITIES TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
           TABLE 100 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
           TABLE 101 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,2018–2025 (USD MILLION
           TABLE 102 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 103 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
    8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
           8.3.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS
           TABLE 104 RECENT MERGERS & ACQUISITIONS AMONG CONTRACT RESEARCH ORGANIZATIONS
           TABLE 105 CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 106 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 107 EUROPE: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 108 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    8.4 ACADEMIC & RESEARCH INSTITUTES
           8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
           TABLE 109 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
           TABLE 110 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 111 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 112 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)

9 CELL-BASED ASSAYS MARKET, BY REGION (Page No. - 119)
    9.1 INTRODUCTION
           TABLE 113 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 20 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
           TABLE 114 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 115 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 116 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 117 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 118 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 119 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 120 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 121 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 With growing R&D funding and recent drug approvals, the US dominates the North American cell-based assays market
           TABLE 122 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 123 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 124 US: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 125 US: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 126 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 127 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 128 US: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Strategic partnerships and collaborations are supporting the growth of the market in Canada
           TABLE 129 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 130 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 131 CANADA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 132 CANADA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 133 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 134 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 135 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.3 EUROPE
           TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 137 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 138 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 139 EUROPE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 140 EUROPE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 141 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,2018–2025 (USD MILLION)
           TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 143 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany dominates the cell-based assays market in Europe
           TABLE 144 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 145 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 146 GERMANY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 147 GERMANY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 148 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 149 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 150 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Focus on cancer research funding will increase the demand for cell-based assays in the country
           TABLE 151 UK: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 152 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 153 UK: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 154 UK: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 155 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 156 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 157 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Increase in R&D funding to drive the growth of the market
           TABLE 158 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 159 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 160 FRANCE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 161 FRANCE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 162 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 163 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 164 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Strategic collaborations in drug discovery have promoted the growth of the cell-based assays market in Italy
           TABLE 165 ITALY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 166 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 167 ITALY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 168 ITALY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 169 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 170 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 171 ITALY: CELL-BASED ASSAYS MARKET, BY END USER,2018–2025 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Availability of funding from private and public organizations is aiding the market growth
           TABLE 172 SPAIN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 173 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 174 SPAIN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 175 SPAIN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 176 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 177 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 178 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.6 REST OF EUROPE
           TABLE 179 ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 180 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 181 ROE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 182 ROE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 183 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 184 ROE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 185 ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 21 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
           TABLE 186 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 187 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 188 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 189 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 190 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 191 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 192 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 193 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Rising R&D capabilities and accelerated drug discovery have created a demand for cell-based assays products and services
           TABLE 194 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 195 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 196 CHINA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 197 CHINA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 198 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 199 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 200 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Government programs to encourage drug discovery has increased the demand for cell-based assays in Japan
           TABLE 201 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 202 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 203 JAPAN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 204 JAPAN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 205 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 206 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 207 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Market growth in India is attributed to increasing investments in R&D and funding for life sciences research
           TABLE 208 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 209 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 210 INDIA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 211 INDIA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 212 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 213 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 214 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
           TABLE 215 ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 216 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 217 ROAPAC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 218 ROAPAC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 219 ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 220 ROAPAC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 221 ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 RISING NUMBER OF CLINICAL TRIAL SITES AND GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
           TABLE 222 LATAM: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 223 LATAM: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 224 LATAM: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 225 LATAM: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 226 LATAM: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 227 LATAM: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 228 LATAM: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 GOVERNMENT EFFORTS TO INCREASE RESEARCH WILL FUEL THE DEMAND FOR CELL-BASED ASSAYS IN THE REGION
           TABLE 229 MEA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 230 MEA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 231 MEA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 232 MEA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 233 MEA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 234 MEA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 235 MEA: CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 175)
     10.1 OVERVIEW
           FIGURE 22 MARKET EVALUATION FRAMEWORK
     10.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS
           FIGURE 23 MARKET SHARE ANALYSIS: 2019
           TABLE 236 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
     10.3 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2019
             10.3.1 STARS
             10.3.2 EMERGING LEADERS
             10.3.3 PERVASIVE COMPANIES
             10.3.4 EMERGING COMPANIES
           FIGURE 24 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019
     10.4 CELL-BASED ASSAYS MARKET: START-UP/SME EVALUATION MATRIX, 2019
             10.4.1 PROGRESSIVE COMPANIES
             10.4.2 STARTING BLOCKS
             10.4.3 RESPONSIVE COMPANIES
             10.4.4 DYNAMIC COMPANIES
           FIGURE 25 CELL-BASED ASSAYS MARKET: STARTUP/SME EVALUATION MATRIX, 2019
     10.5 KEY MARKET DEVELOPMENTS
             10.5.1 KEY PRODUCT LAUNCHES
             10.5.2 KEY ACQUISITIONS
             10.5.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
             10.5.4 KEY EXPANSIONS

11 COMPANY PROFILES (Page No. - 184)
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)* 
     11.1 THERMO FISHER SCIENTIFIC
           FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
     11.2 DANAHER CORPORATION
           FIGURE 27 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     11.3 MERCK KGAA
           FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2019)
     11.4 BECTON, DICKINSON AND COMPANY
           FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
     11.5 LONZA GROUP
           FIGURE 30 LONZA GROUP AG: COMPANY SNAPSHOT
     11.6 PERKINELMER
           FIGURE 31 PERKINELMER: COMPANY SNAPSHOT (2019)
     11.7 CHARLES RIVER LABORATORIES
           FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019)
     11.8 EUROFINS SCIENTIFIC SE
           FIGURE 33 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2019)
     11.9 ENZO BIOCHEM
           FIGURE 34 ENZO BIOCHEM: COMPANY SNAPSHOT (2019)
     11.10 PROMEGA CORPORATION
     11.11 CARNA BIOSCIENCES, INC.
           FIGURE 35 CARNA BIOSCIENCES: COMPANY SNAPSHOT (2020)
     11.12 CELL BIOLABS
     11.13 CELL SIGNALING TECHNOLOGY
     11.14 BIOAGILYTIX LABS INC.
     11.15 REACTION BIOLOGY CORPORATION
     11.16 AAT BIOQUEST, INC.
     11.17 PBL ASSAY SCIENCE
     11.18 INVIVOGEN
     11.19 CA3 BIOSCIENCES INC. (NEUROMICS)
     11.20 BPS BIOSCIENCE
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 233)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global cell-based assays market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the cell-based assays market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

The secondary sources referred to for this research study include publications from government sources, such as the American Society for Cell Biology (ASCB), Federal Ministry of Education and Research (BMBF), Center for Commercialization of Regenerative Medicine (CCRM), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Agency for Research on Cancer (IARC), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Cancer Research Fund International (WCRF), World Health Organization (WHO), and Eurostat, among others. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global cell-based assays market, which was validated through primary research.

Primary Data

Extensive primary research was conducted after acquiring basic knowledge about the global cell-based assays market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in contract research organizations) and supply side (such as C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering cell-based assays) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Primary research was used in this report to:

  • Validate the market segmentation defined through a product and service portfolio assessment of the leading players in the cell-based assays market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the cell-based assays market and their market shares/rankings

Cell-based Assays Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the cell-based assays market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the  cell-based assays market

Report Objectives

  • To define, describe, and forecast the global cell-based assays market based on product & service, application, end user, and region.
  • To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, and opportunities).
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall cell-based assays market.
  • To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile the key players and comprehensively analyze their market shares and core competencies.
  • To track and analyze competitive developments such as new product & service launches; acquisitions; expansions; and partnerships, collaborations, and agreements

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the European cell-based assays market into countries from the Rest of Europe segment.
  • Further breakdown of the Asia Pacific cell-based assays market into countries from the Rest of the APAC segment.
  • Further breakdown of Latin America and the Middle East & Africa cell-based assays market into countries.

Company Information

Detailed analysis and profiling of additional market players (up to 5) inclusive of:

  • Business Overview
  • Financial Information
  • Product Offered
  • Developments (Last three years)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Cell-based Assays Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Cell-based Assays Market

Request For Special Pricing
Report Code
BT 2486
Published ON
Mar, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell-based Assays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home